Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Nov 18, 2026
TickeronGET DAILY SIGNALS
Why Is iHuman Inc. (IH) Stock Down -21.84% Today?

Why Is iHuman Inc. (IH) Stock Down -21.84% Today?

Key Takeaways

  • IH shares fell 21.84% in Wednesday morning trading, with the ADR last changing hands near $0.78 versus the prior close of $1.00.
  • No verified company news, filing, analyst action, or fundamental development was found to explain the decline.
  • The move appears liquidity-driven: the stock trades only a few thousand shares a day, and a single 1,000-share print was enough to shift the quoted price by more than a fifth.
  • The sell-off extends a months-long downtrend — the ADR is down roughly 64% over the past year and has lost about a quarter of its value since early November.
  • Fundamental backdrop remains soft after second-quarter revenue fell 18% year over year and the company swung to a net loss.
  • News Significance Score: 46/100 — no verified catalyst paired with a price move nearly nine times the stock's typical daily swing.
  • Traders will watch whether the $1.00 area becomes resistance, whether volume broadens beyond a few thousand shares, and the next earnings release expected in late December.
  • Investors can find detailed Price Targets, Earnings history, and Forecast data on the dedicated Tickeron pages for this ticker.
  • For systematic, rules-based ideas across the market, explore Trending AI Robots.

Opening Summary

iHuman Inc. (IH) is a Beijing-based children's education technology company that sells subscription-based interactive learning apps and physical learning materials, primarily in mainland China. Its American depositary shares trade on the New York Stock Exchange. On Wednesday, the stock was quoted at $0.78, down 21.84% from the previous session's close of $1.00 — a decisive move lower. No verified corporate, regulatory, or analyst catalyst was identified for the drop, and the price action is consistent with the order-book fragility of a micro-cap that averages only a few thousand shares of daily turnover.

No verified news or fundamental catalyst found

No verified news or fundamental catalyst found in company disclosures, wire reports, or analyst coverage explains Wednesday's decline. There was no earnings release, no SEC filing, no financing, and no rating change around the time of the move. The most plausible explanation is mechanical rather than fundamental.

Wednesday's quoted volume was approximately 1,000 shares — a fraction of the roughly 6,400-share three-month average and a small share of the float, which stands at about 14 million shares with insiders holding roughly 72% of the company. Quoted bid-ask spreads have recently run between roughly $0.44 and $1.27 for orders of only a few hundred shares, a spread wide enough that a single market order can reprice the tape by double digits. The decline is consistent with a thin order book and an isolated trade establishing a new low, rather than a reassessment of the company's value.

Wednesday's move is also in line with a stock that has repeatedly swung by double digits without news: shares rose 12.39% on Nov. 9 and then fell 19.69% the following session, both on modest volume. The stock is a habitual large mover, which makes today's percentage decline less informative than the headline suggests.

Fundamental Backdrop Remains Weak

The larger trend is not in dispute. iHuman's second-quarter 2026 results, reported Sept. 29, showed revenue of RMB 173.4 million, down about 18% year over year, alongside a net loss as operating expenses rose. Management cited a persistently challenging operating environment. The company has also been active on acquisitions, having completed a deal for the businesses behind its All Knowledge and Perfect Lingo products earlier in 2026. That combination — contracting top line, thin profitability, and an ADR that has lost about 64% over twelve months — leaves little fundamental cushion under the shares and makes the equity prone to sharp, low-volume repricing.

Market Context and Trading Activity

Volume on Wednesday was well below normal rather than elevated, which argues against a conviction-driven institutional exit and points instead to a liquidity event in an illiquid name. The decline pushed the ADR below its previous 52-week low of $0.99 and further beneath its 50-day moving average near $1.15 and its 200-day average near $1.48 — a breakdown of the narrow $0.99–$1.27 range the stock has held since early November. The move was idiosyncratic: iHuman's beta is close to zero, its institutional ownership is minimal, and there is no sign the decline reflected a sector-wide or index-level event. For a security this thinly traded, technical levels are more descriptive than predictive, but the loss of the $1.00 handle is the clearest signal on the chart.

News Significance Score

The score runs from 0, meaning no meaningful news and a price move entirely normal for the stock, to 100, meaning transformative news and an extreme, rare move. iHuman's score is 46 out of 100.

Verified news strength was essentially nil — no disclosure or development was found, so catalyst strength contributed almost nothing. The price move, however, was highly unusual for the stock's recent history: it was roughly 8.8 times the 2.5% average absolute daily change of the past 60 sessions, and a move of this size did not occur once in that window. Those two components combine to a mid-range score: an exceptional move without an identifiable cause.

What Comes Next for IH

The next scheduled catalyst is the company's third-quarter 2026 results, expected in late December. Investors will focus on whether revenue declines stabilize, whether operating expenses can be contained, and whether management returns to profitability. The company carries a large net cash position relative to its market capitalization and pays an annual dividend, both of which are worth monitoring given the share price's slide. There is no meaningful sell-side coverage or consensus estimate for the current fiscal year, which limits visibility. Key risks include continued demand weakness in Chinese children's education spending, currency translation effects on the RMB-denominated business, the widening gap between the quoted bid and ask, and the possibility that the shares remain range-bound without a clear fundamental trigger.

Trending AI Robots

Tickeron offers hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market conditions make it into the curated Trending AI Robots section. The bots differ widely by strategy, holding timeframe, performance metrics, and the symbols they trade, so the lineup shifts as market conditions change. Reviewing the current leaders can help traders compare approaches and identify which automated strategies are working right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IH

Contributor

Dem Sem's AvatarDem Sem|Expert

IH in downward trend: 10-day moving average moved below 50-day moving average on November 10, 2026

The 10-day moving average for IH crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IH as a result. In 97 of 111 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

The Moving Average Convergence Divergence Histogram (MACD) for IH turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 46 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.

IH moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for IH's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

IH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.069) is normal, around the industry mean (1.158). P/E Ratio (2.511) is within average values for comparable stocks, (8.484). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.327). Dividend Yield (0.354) settles around the average of (4.151) among similar stocks. P/S Ratio (0.537) is also within normal values, averaging (27.566).

The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. IH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are TAL Education Group (NYSE:TAL).

Industry description

‘Other Consumer Specialties’ represents an industry that typically sells durable consumer products, but do not have a classification in another category. The products include jewelry, smoke detectors, watches, collectibles and safety products. MSA Safety (makes products which enhances the safety and health of workers and protect facility infrastructures), Matthews International (memorialization business), Fitbit (makes wireless-enabled wearable technology devices that gauge data such as the number of steps walked, heart rate, quality of sleep), and Fossil Group (makes watches and accessories) have some of the largest market caps in this group.

Market Cap

The average market capitalization across the Other Consumer Specialties Industry is 1.03B. The market cap for tickers in the group ranges from 90 to 15B. PANDY holds the highest valuation in this group at 15B. The lowest valued company is BSEFY at 90.

High and low price notable news

The average weekly price growth across all stocks in the Other Consumer Specialties Industry was -7%. For the same Industry, the average monthly price growth was -20%, and the average quarterly price growth was -29%. FEDU experienced the highest price growth at 27%, while JDZG experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Other Consumer Specialties Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was 34% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 60
Price Growth Rating: 74
SMR Rating: 78
Profit Risk Rating: 87
Seasonality Score: -4 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry OtherConsumerSpecialties

Industry
N/A
Address
No. 86 Beiyuan Road
Phone
+86 1057806606
Employees
558
Web
https://www.ihuman.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
CBRS fell -6.07% to $97.86 in the opening minutes of Wednesday's regular session, down from Tuesday's close of $104.18 — the move occurred during market hours, not premarket or after-hours. No verified news or fundamental catalyst found: no new filing, contract, or analyst action explains the drop, which is likely continued give-back from the post-earnings pop and the stock's habitual volatility — CBRS has averaged a ±4.5% daily swing over the past 60 sessions, and 17 of those sessions moved as much or more.
NVIDIA reported revenue of $115.84 billion for the third quarter of fiscal 2027, up 103% year over year and ahead of both company guidance and consensus estimates. Non-GAAP earnings per share (EPS, a measure of profit per outstanding share) came in at $2.68 , beating the roughly $2.47 analysts had expected.